R es u lt R ep o rt

PatientID:
Record Date: 2025-09-18 08:24:47
Barcode: 5946554E E
Sam pleNo: 09180008
CALIB : Y = 1.1308X + 0.6219

NAME % TIME AREA

A1A 0.4 0.24 5.44

A1B 0.5 0.32 6.62

F 0.5 0.39 7.02

LA1C+ 1.3 0.55 17.69

SA1C 4.6 0.68 50.24

A0 94.2 1.03 1304.63

TOTAL ARE A 1391.64
H b A 1C 4. 6 %
HbA1 5.5 % HbF 0.5 %
[%]
15.0

10.0

5.0

0.0

0.00 1.00 2.00

[Min]

2025-09-18 08:50 root Page: 1 / 1

 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 08:28AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

HEALTH PLUS 3.4

Complete Haemogram (CHG)
*Total Leucocyte Count (WBC) 4.4 thou/cu.mm 4.0 - 11.5 Laser-based Flow Cytometry

Uncorrected White Blood Cell Count NA

(UWBC)
*Total Red Blood Count (RBC) 3.74 m/cumm 4.00 - 5.40 Electrical Impedance

*Haemoglobin (HGB) 12.2 gm/dL 12.4 - 14.9 Colorimetric Method

*Haematocrit (PCV) 38.0 % 40 - 54 Calculated

*Mean Corpuscular Volume (MCV) 101.6 fL 80 - 94 Calculated

*Mean Corpuscular Haemoglobin 32.6 pg 26 - 32 Calculated

(MCH)
*Mean Corpuscular Haemoglobin 32.1 g/dL 32 - 36 Calculated
Concentration (MCHC)
Red Cell Distribution Width (RDW- 49.1 %
SD)
Red Cell Distribution Width - Standard 12.60 11.5 - 14.5
Deviation (RDW-CV)
*Platelet Count (PLT) 161.00 thou/cumm 150.00 - 450.00 Electrical Impedance &
Microscopy
Mean Platelet Volume (MPV) 13.50

Platelet Distribution Width (PDW) 19.50

Plateleterit (PCT) 0.21

Platelet Large Cell Ratio (PLRC) 52.10 %

Differential Leucocyte Count (DC)

*Neutrophils Percentage Count 35 % 50 - 70 Flowcytometry/Microscopy
(NE%)
*Neutrophil Absolute Count (NEU) 1,540 /cu.mm 2000 - 7000 Flowcytometry/Microscopy

*Lymphocytes Percentage Count 53 % 18 - 42 Flowcytometry/Microscopy

(LY%)
*Lymphocyte Absolute Count (LYM) 2,332 /cu.mm 1800 - 4200 Flowcytometry/Microscopy

*Monocytes Percentage Count (MO%) 05 % 2 - 11 Flowcytometry/Microscopy

*Monocyte Absolute Count (MO) 220 /cu.mm 200 - 1000 Flowcytometry/ Microscopy

*Eosinophil Percentage Count 07 % 1-3 Flowcytometry/Microscopy

(ESO%)
** SAMPLE PROCESS AT RPL LUCKNOW **

Page 1 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 08:28AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

*Eosinophil Absolute Count (EOS) 308 /cu.mm 20 - 500 Flowcytometry/Microscopy

*Basophils Percentage Count (BAS%) 00 % 0-2 Electrical

Impedance/Microscopy
*Basophils Absolute Count (BAS) 0.00 /cu.mm 0.00 - 0.20 Electrical
Impedance/Microscopy
Nucleated Red Blood Cells (NRBC) NA

Early Granulated Cell Absolute Count NA

(EGC)
Early Granulated Cell Percent NA
(EGC%)
Low Haemoglobin Density (LHD) NA

Microcytic Anemia Factor (MAF) NA

Erythrocyte Sedimentation Rate (ESR) 14 mm/hr 0 - 20 Modified Wstergren

Peripheral Blood Smear for Morphology MICROSCOPY

RBC : NORMOCYTIC NORMOCHROMIC .

Sample Type:Whole Blood EDTA

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 2 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 09:05AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

VITAMIN PANEL
Vitamin B12 (Cyanocobalamin) 920 pg/mL 187 - 883 ECLIA

Vitamin D Total 25 Hydroxy (Calcidiol) 16.74 ng/mL Deficiency < 20.00 ECLIA
Insufficiency 21.00 - 30.00
sufficiency 31.00 - 100.00
Toxicity > 100.00
Sample Type:Serum

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 3 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 09:05AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

Thyroid Panel
*Total Triiodothyronine (T3) 1.34 ng/mL Hypothyroid < 0.80 ECLIA
Euthyroid 0.80 - 2.00
Hyperthyroid > 2.00
*Total Thyroxine (T4) 6.41 µg/dL Hypothyroid < 5.10 ECLIA
Euthyroid 5.10 - 14.10
Hyperthyroid > 14.10
*TSH (3rd Generation) 3.620 µIU/mL Hyperthyroid < 0.270 ECLIA
Euthyroid 0.270 - 4.200
Hypothyroid > 4.200
Sample Type:Serum
Interpretation :
Thyroid Stimulating Hormone is a glycoprotein with two – covalently bound subunits.The alpha subunit is similar to those of follicle stimulating hormone (FSH), human
chorionic gonadotrophin (hCG) and Luteinizing Hormone (LH).The beta submit of TSH is unique, which results in the specific biochemical and immunological properties of this
hormone.TSH is synthesized and secreted by the anterior pituitary in response to a negative feedback mechanism involving concentrations of FT3 (Free T3) and FT4 (Free
T4).Additionally, the hypothalamic tripeptide, thyrotropoin – releasing hormone (TSH), directly stimulates TSH production.TSH interacts with specific cell receptors on the
thyroid cell surface and exerts two main actions.The first action is to stimulate cell reproduction and hypertrophy.Secondly,TSH stimulates the thyroid gland to synthesize
and secrete T3 and T4 .In primary hypothyroidism, TSH levels are significantly elevated, while in secondary and tertiary hypothyroidism TSH levels are low.

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 4 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 10:06AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

Kidney Function Test (KFT)

*Urea 22 mg/dL 16 - 48 Kinetic UV Assay

Blood Urea Nitrogen (BUN) 10 mg/dL 8 - 23 Calulated

*Creatinine (CREA) 0.71 mg/dL 0.70 - 1.20 Jaffe Kinetic Colorimetric

Calcium (CA) 9.5 mg/dL 8.4 - 10.2 Arsenazo III

*Sodium (Na+) 143 mmol/L 135 - 145 Indirect ISE

*Potassium (K+) 4.27 mmol/L 3.50 - 5.10 Indirect ISE

*Chloride (Cl-) 98 mmol/L 98 - 107 Indirect ISE

Phosphorus Inorganic (PHOS) 3.9 mg/dL 2.5 - 5.0 Phosphomolybdate UV

*Uric Acid (UA) 5.9 mg/dL 3.4 - 7.0 Enzymatic Colorimetric

Estimated Glomerular Filteration Rate 111.00 mL/min/1.73m² MDRD Method

(EGFR ) Normal : >= 90
BUN to Creatinine Ratio 14.46 Ratio Calculated

Urea & Creatinine Ratio 2.14 mg/dL Calculated

Sample Type:Serum

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 5 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 09:54AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

DIABETIC PANEL
HbA1c (Glycosylated Haemoglobin) 4.6 % Normal/Low Risk < 5.7 HPLC
Pre-Diabetes/High Risk Diabetes 5.7 -
6.5%
Diabetes >6.5%
Estimated Average Glucose 85 mg/dL If HBA1c Value 4% - 6% HPLC
Normal 70 - 126
Comment

.
Sample Type:Whole Blood EDTA
REMARKS :
In vitro quantitative determination of HbA1c in whole blood is utilized in long term monitoring of glycemia.The HbA1c level correlates with the mean glucose concentration prevailing in the course of the
patient's recent history (approx - 6-8 weeks) and therefore provides much more reliable information for glycemia monitoring than do determinations of blood glucose or urinary glucose. It is recommended that the
determination of HbA1c be performed at intervals of 4-6 weeks during Diabetes Mellitus therapy. Results of HbA1c should be assessed in conjunction with the patient's medical history, clinical examinations and other
findings.

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 6 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 10:06AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

Liver Function Test (LFT)

*Bilirubin (Total) 0.38 mg/dL 0.00 - 1.00 Diazo

Bilirubin (Direct/Conjugated) 0.14 mg/dL 0.00 - 0.20 Diazo

Bilirubin (Indirect/Unconjugated) 0.24 mg/dL 0.00 - 1.00 Diazo

*Alanine Aminotransferase(ALT/SGPT) 20 U/L < 50 IFCC with Pyridoxal

Phosphate
Aspartate Aminotransferase (AST/SGOT) 27 U/L < = 40 IFCC without pyridoxal
phosphate
*Alkaline Phosphatase (ALP) 64 U/L 40 - 129 IFCC-PNPP

*Protein Total (TP) 6.7 g/dL 6.4 - 8.2 Biuret

Albumin (ALB) 3.7 g/dL 3.5 - 5.2 BCG - Colorimetric

*Globulin (GLO) 3.0 g/dL 2.3-3.5 Calculated

*Gamma Glutamyl Transferase (GGT) 32 U/L 15 - 85 Enzymatic Colorimetric Assay

*Albumin to Globulin (A/G) Ratio 1.2 Ratio 1.1 - 2.2 Calculated

*SGOT (AST) to SGPT(ALT) Ratio 1.35 Ratio Calculated

Sample Type:Serum

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 7 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 10:06AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

Lipid Profile
*Cholesterol Total (CHOL) 127 mg/dL Desirable: <200 CHOD Enzymetic Colorimetric
Borderline High: 200-239
High: >=240
*Cholestrol (HDL) 35 mg/dL High Risk: <40 Homogeneous Enzymatic
Moderate Risk: 40 - 60 Colorimetric
No Risk: >60
Cholesterol NON HDL 92.00 Calculated

*Triglycerides (TRIG) 57 mg/dL Normal: <150 GPO - PAP

BorderLine: 150-199
High: 200-499
Very High: >=500
Cholesterol LDL 80 mg/dL Optimal: <100 Homogeneous Enzymetic
Above Optimal: 100-129 Colorimetric
Boderline High: 130-159
High: 160-190
Very High: 190
Cholesterol (VLDL) 12 mg/dL < 30 Calculated

*CHOL Total to CHOL HDL Ratio 3.63 Ratio Low Risk: 3.3 - 4.4 Calculated
Average Risk: 4.5 - 7.0
Moderate Risk: 7.1 - 11.0
High Risk: >=11
CHOL LDL to CHOL HDL Ratio 2.3 Ratio Desirable/Low Risk: 0.5 - 3.0 Calculated
Borderline/Moderate Risk: 3.1 - 6.0
High Risk: > 6.0
CHOL Total to CHOL LDL Ratio 1.6 Ratio Calculated

*TRIG to CHOL HDL Ratio 2 Calculated

ASCVD Risk Estimator NA % 10-year risk for ASCVD is categorized Calculated

as:
Low-risk (<5%)
Borderline risk (5% to 7.4%)
Intermediate risk (7.5% to 19.9%)
High risk (≥20%)
Sample Type:Serum

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 8 of 9
 Name: Mr. BHAYLAL JAISWAL Client Name: HPD LKO-009 Barcode No.: 5946554
PATIENT DETAILS

REPORT DETAILS
CLIENT DETAILS
Age/Gender: 67 Y/Male Client Address: VARANASI Collected on: 17/Sep/2025 10:09PM
Lab No: 102509170329
Referred By: Dr. S S H BHU Reported on: 18/Sep/2025 10:06AM
Ref Lab/Hospital.: Self @1

Test Name Result Unit Biological Ref.Interval Method

Iron Studies
*Iron 130 µg/dL 33 - 193 FerroZine

Unsaturated Iron Binding Capacity 225 µg/dL 110 - 370 FerroZine

(UIBC)
Total Iron Binding Capacity 355 ug/dl 250 - 400 Spectrophotometry

Transferrin Saturation 37 % 20 - 55 Calculated

Sample Type:Serum

Test has been performed on LKO_Cobas_6000

For test performed on specimens received or collected from non-HPDPL locations, it is presumed that the specimen belongs to the patient named or identified as labeled on the container/test request and such verification has been carried out at the
point generation of the said specimen by the sender. HPDPL will be responsible only for the analytical part of test carried out. All other responsibility will be of referring Laboratory.

*** End Of Report ***

** SAMPLE PROCESS AT RPL LUCKNOW **

Page 9 of 9